Herein, we report a patient with a giant adrenal myelolipoma that presented with retroperitoneal hemorrhage and underwent emergency surgery.
Figure 2. Macroscopic view of the excised right adrenal gland
Figure 3. AB: Microscopic examination of the surgical specimen, showing adipocytes and myeloid cells
Myelolipomas are usually asymptomatic. However, in some patients, symptoms such as abdominal pain, hypochondriac pain, abdominal mass, back pain, fever, weight loss, shortness of breath and endocrine disorders may be seen [2]. These patients usually present with sudden onset of severe abdominal pain, nausea, and vomiting. Unless promptly intervened, the condition progresses to life-threatening shock due to hypotension.
In diagnosis of AM, imaging methods such as ultrasonography, CT, magnetic resonance imaging (MRI) are used [3]. The most sensitive diagnostic imaging method is CT. Lesions are seen on CT as contrast-enhancing, hypodense, well-circumscribed, heterogeneous masses with an attenuation value ranging from −20 to −120 HU depending on their myeloid and adipose tissue content [4]. However, it may be difficult to distinguish the lesions from the surrounding retroperitoneal adipose tissue due to the abundant fat content of some masses.
The clinical condition of the patient and the size of the lesion should be taken into consideration in the management of AMs. Asymptomatic lesions smaller than 10 cm in diameter should be followed up with imaging methods for 1 or 2 years. If symptoms occur, surgery is recommended. Asymptomatic masses bigger than 10 cm in diameter should be surgically excised due to the possibility of life-threatening retroperitoneal bleeding in case of spontaneous rupture, as in the case presented [5]. In cases with smaller mass lesions, minimal invasive or endoscopic procedures can be applied. Transabdominal, lumbar, subcostal, or posterior approach may be preferred for surgical excision [2]. After adrenalectomy, myelolipoma may also develop in the contralateral adrenal gland [5]. Therefore, patients should be followed up regularly in the postoperative period.
Ethics Committee Approval: N / A
Informed Consent: Written informed consent was obtained from patient.
Publication: The results of the study were not published in full or in part in form of abstracts.
Peer-review: Externally and internally peer-reviewed. Authorship Contributions: Any contribution was not made by any individual not listed as an author. Concept – S.C., M.B.; Design – S.C., M.B.; Supervision – S.C., A.T. Resources – S.K., H.G., O.G.; Materials – S.K., H.G., O.G.; Data Collection and/ or Processing – S.K., H.G., O.G.; Analysis and/or Interpretation – S.C., M.B.; Literature Search – S.K., H.G., O.G.; Writing Manuscript – S.C., M.B.; Critical Review – S.C., A.T.
Conflict of Interest: The authors declare that they have no conflict of interest.
Financial Disclosure: The author declare that this study received no financial support.
1) Caleo O, Bocchini G, Paoletta S, Ierardi AM, Scionti A,
Tonerini M, et al. Spontaneous non-aortic retroperitoneal
hemorrhage: etiology, imaging characterization and
impact of MDCT on management. A multicentric study.
Radiol Med 2015;120:133-48.
https://doi.org/10.1007/s11547-014-0482-0
2) Bokhari MR, Zulfiqar H, Garla VV. Adrenal Myelolipoma.
[Updated 2022 Jul 5]. In: StatPearls [Internet]. Treasure
Island (FL): StatPearls Publishing; 2022 Jan-. Available
from:
https://www.ncbi.nlm.nih.gov/books/NBK436011/
3) Amano T, Takemae K, Niikura S, Kouno M, Amano M.
Retroperitoneal hemorrhage due to spontaneous rupture of
adrenal myelolipoma. Int J Urol 1999;6:585-8.
https://doi.org/10.1046/j.1442-2042.1999.611109.x
4) Kabeel K, Marjara J, Bhat R, Gaballah AH, Abdelaziz
A, Bhat AP. Spontaneous hemorrhage of an adrenal
myelolipoma treated with transarterial embolization: A
case report. Radiol Case Rep 2020;15:961-5.
https://doi.org/10.1016/j.radcr.2020.04.034